Development and validation of a risk prediction model for patients with hepatocellular carcinoma receiving atezolizumab–bevacizumab

The CRAPT-M model demonstrated robust OS prediction, offering a valuable tool for prognosis estimation and clinical decision-making in advanced HCC patients receiving AB.

Authors

Institutions

Publication Details

Journal
Hepatology
Published
2025-06-30
DOI
https://doi.org/10.1097/hep.0000000000001444
Citations
3
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
3.97
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development and validation of a risk prediction model for patients with hepatocellular carcinoma receiving atezolizumab–bevacizumab

Dong Yun Kim, Ji Won Han, Ji Hoon Kim, Do Seon Song et al.
3 citations
Hepatology
Hepatocellular Carcinoma Treatment and Prognosis
3.97
article

Development and validation of a risk prediction model for patients with hepatocellular carcinoma receiving atezolizumab–bevacizumab

Dong Yun Kim, Ji Won Han, Ji Hoon Kim, Do Seon Song, U I. Chang, Pil Soo Sung, Si Hyun Bae, Jeong Won Jang, Soon Woo Nam, Ahlim Lee, Soon Kyu Lee, Seung Kew Yoon, Chang Wook Kim, Hyun Yang, Jung Hyun Kwon, Myung Jun Song, Hae Lim Lee, Heechul Nam, Seok-Hwan Kim, Do Young Kim, Sung Won Lee, Jaejun Lee, Hee Yeon Kim, Keungmo Yang, Hee Sun Cho
article en
3 citations

Abstract

The CRAPT-M model demonstrated robust OS prediction, offering a valuable tool for prognosis estimation and clinical decision-making in advanced HCC patients receiving AB.

Hepatology
Yonsei University (KR), The Catholic University of Korea St. Vincent's Hospital (KR), The Catholic University of Korea Incheon St. Mary's Hospital (KR), The Catholic University of Korea Uijeongbu St. Mary's Hospital (KR), The Catholic University of Korea Daejeon St. Mary's Hospital (KR), The Catholic University of Korea Bucheon St. Mary's Hospital (KR), The Catholic University of Korea Seoul St. Mary's Hospital (KR), Catholic University of Korea (KR)
Good health and well-being
Openalex Percentile: Top 6%
Hepatocellular Carcinoma Treatment and Prognosis
3.97
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.